These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 35232787)

  • 1. Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020-17 May 2021): a population-level observational study.
    Tessier E; Rai Y; Clarke E; Lakhani A; Tsang C; Makwana A; Heard H; Rickeard T; Lakhani S; Roy P; Edelstein M; Ramsay M; Lopez-Bernal J; White J; Andrews N; Campbell CNJ; Stowe J
    BMJ Open; 2022 Mar; 12(3):e055278. PubMed ID: 35232787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: Two retrospective cohort analyses of the primary schedule and third dose.
    Morrison K; Cullen L; James AB; Chua V; Sullivan C; Robertson C; Carruthers J; Wood R; Jeffrey K; MacDonald C; Shah SA; Rudan I; Simpson CR; McCowan C; Vittal Katikireddi S; Grange Z; Ritchie L; Sheikh A
    Vaccine; 2023 Sep; 41(40):5863-5876. PubMed ID: 37598025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic inequities in routine childhood vaccinations in England 2006-2021: an observational cohort study using electronic health records.
    Zhang CX; Bankhead C; Quigley MA; Kwok CH; Carson C
    EClinicalMedicine; 2023 Nov; 65():102281. PubMed ID: 37965428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the impact of using mobile vaccination units to increase COVID-19 vaccination uptake in Cheshire and Merseyside, UK: a synthetic control analysis.
    Zhang X; Tulloch JSP; Knott S; Allison R; Parvulescu P; Buchan IE; Garcia-Finana M; Piroddi R; Green MA; Baird S; Barr B
    BMJ Open; 2023 Oct; 13(10):e071852. PubMed ID: 37802621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
    ; Parker EP; Tazare J; Hulme WJ; Bates C; Carr EJ; Cockburn J; Curtis HJ; Fisher L; Green AC; Harper S; Hester F; Horne EM; Loud F; Lyon S; Mahalingasivam V; Mehrkar A; Nab L; Parry J; Santhakumaran S; Steenkamp R; Sterne JA; Walker AJ; Williamson EJ; Willicombe M; Zheng B; Goldacre B; Nitsch D; Tomlinson LA
    BMJ Open; 2023 Jan; 13(1):e066164. PubMed ID: 36720568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National surveillance data analysis of COVID-19 vaccine uptake in England by women of reproductive age.
    Magee LA; Molteni E; Bowyer V; Bone JN; Boulding H; Khalil A; Mistry HD; Poston L; Silverio SA; Wolfe I; Duncan EL; von Dadelszen P;
    Nat Commun; 2023 Feb; 14(1):956. PubMed ID: 36813760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimensions of equality in uptake of COVID-19 vaccination in Wales, UK: A multivariable linked data population analysis.
    Jones G; Perry M; Bailey R; Arumugam S; Edwards A; Lench A; Cooper A; Akbari A; Collins B; Harris C; Richardson G; Barry M; Harris P; Fry R; Lyons RA; Cottrell S
    Vaccine; 2023 Nov; 41(49):7333-7341. PubMed ID: 37932133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does vulnerability to COVID-19 vary between communities in England? Developing a Small Area Vulnerability Index (SAVI).
    Daras K; Alexiou A; Rose TC; Buchan I; Taylor-Robinson D; Barr B
    J Epidemiol Community Health; 2021 Aug; 75(8):729-734. PubMed ID: 33542030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmet need for COVID-19 vaccination coverage in Kenya.
    Muchiri SK; Muthee R; Kiarie H; Sitienei J; Agweyu A; Atkinson PM; Edson Utazi C; Tatem AJ; Alegana VA
    Vaccine; 2022 Mar; 40(13):2011-2019. PubMed ID: 35184925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the Effectiveness of First Dose of COVID-19 Vaccine Against Mortality in England: A Quasi-Experimental Study.
    Bermingham C; Morgan J; Ayoubkhani D; Glickman M; Islam N; Sheikh A; Sterne J; Walker AS; Nafilyan V
    Am J Epidemiol; 2023 Feb; 192(2):267-275. PubMed ID: 36065824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inequalities in SARS-CoV-2 case rates by ethnicity, religion, measures of socioeconomic position, English proficiency, and self-reported disability: cohort study of 39 million people in England during the alpha and delta waves.
    Larsen T; Bosworth ML; Ayoubkhani D; Schofield R; Ali R; Khunti K; Walker AS; Glickman M; Harrison C; Nafilyan V
    BMJ Med; 2023; 2(1):e000187. PubMed ID: 37063237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neighbourhood sociodemographic factors and COVID-19 vaccine uptake in the Netherlands: an ecological analysis.
    Labuschagne LJE; Smorenburg N; van de Kassteele J; Bom B; de Weerdt AC; de Melker HE; Hahné SJM
    BMC Public Health; 2023 Sep; 23(1):1696. PubMed ID: 37660018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccination coverage for half a million non-EU migrants and refugees in England.
    Burns R; Wyke S; Eyre MT; Boukari Y; Sørensen TB; Tsang C; Campbell CNJ; Beale S; Zenner D; Hargreaves S; Campos-Matos I; Harron K; Aldridge RW
    Nat Hum Behav; 2024 Feb; 8(2):288-299. PubMed ID: 38049560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic inequities in 6-8 week baby check coverage in England 2006-2021: a cohort study using the Clinical Practice Research Datalink.
    Zhang CX; Quigley MA; Bankhead C; Kwok CH; Parekh N; Carson C
    Br J Gen Pract; 2024 Apr; ():. PubMed ID: 38621807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHALLENGES IN ESTIMATING THE EFFECTIVENESS OF 2 DOSES OF COVID-19 VACCINE BEYOND 6 MONTHS IN ENGLAND.
    Horne EMF; Hulme WJ; Keogh RH; Palmer TM; Williamson EJ; Parker EPK; Walker VM; Knight R; Wei Y; Taylor K; Fisher L; Morley J; Mehrkar A; Dillingham I; Bacon S; Goldacre B; Sterne JAC; OpenSAFELY Collaborative FT
    Am J Epidemiol; 2024 Jan; 193(1):227-231. PubMed ID: 37656609
    [No Abstract]   [Full Text] [Related]  

  • 16. Author Correction: National surveillance data analysis of COVID-19 vaccine uptake in England by women of reproductive age.
    Magee LA; Molteni E; Bowyer V; Bone JN; Boulding H; Khalil A; Mistry HD; Poston L; Silverio SA; Wolfe I; Duncan EL; von Dadelszen P;
    Nat Commun; 2023 Sep; 14(1):5655. PubMed ID: 37704620
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors associated with COVID-19 vaccine uptake in adolescents: a national cross-sectional study, August 2021-January 2022, England.
    Aiano F; Ireland G; Powell A; Campbell CNJ; Judd A; Davies B; Saib A; Mangtani P; Nguipdop-Djomo P; ; Ladhani SN
    BMJ Open; 2023 Sep; 13(9):e071707. PubMed ID: 37775287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort.
    Joy M; Agrawal U; Fan X; Robertson C; Anand SN; Ordonez-Mena J; Byford R; Goudie R; Jamie G; Kar D; Williams J; Marsden GL; Tzortziou-Brown V; Sheikh SA; Hobbs FDR; de Lusignan S
    Lancet Reg Health Eur; 2023 Sep; 32():100681. PubMed ID: 37671127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Within-Country Inequality in COVID-19 Vaccination Coverage: A Scoping Review of Academic Literature.
    Bergen N; Johns NE; Chang Blanc D; Hosseinpoor AR
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes towards coronavirus (COVID-19) vaccine and sources of information across diverse ethnic groups in the UK: a qualitative study from June to October 2020.
    Sides E; Jones LF; Kamal A; Thomas A; Syeda R; Kaissi A; Lecky DM; Patel M; Nellums L; Greenway J; Campos-Matos I; Shukla R; Brown CS; Pareek M; Sollars L; Pawson E; McNulty C
    BMJ Open; 2022 Sep; 12(9):e060992. PubMed ID: 36581971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.